Illness progression in chronic fatigue syndrome: a shifting immune baseline.
Lindsey RussellGordon BroderickRenee TaylorHenrique FernandesJeanna HarveyZachary BarnesAnneLiese SmylieFanny ColladoElizabeth G BalbinBen Z KatzNancy G KlimasMary Ann FletcherPublished in: BMC immunology (2016)
These preliminary results suggest that IL-1α, 6 and 8 adjusted for illness duration may serve as robust biomarkers, independent of age, in screening for ME/CFS.